| Characteristics . | Values . |
|---|---|
| Age (years) | 65.8 ± 9.2 |
| Gender (male/female) | 51/29 |
| Duration of disease (years) | 13.6 ± 4.9 |
| eGFR (mL/min/1.73 m2) | 49.8 ± 19.5 |
| SBP (mmHg) | 129.1 ± 12.1 |
| DBP (mmHg) | 78.8 ± 10.3 |
| Hg, g/L (g/dL) | 129 ± 15 (12.9 ± 1.5) |
| HgA1c, % | 7.1 ± 1.3 |
| Calcium, mmol/L (mg/dL) | 2.35 ± 0.175 (9.4 ± 0.7) |
| Phosphorus, mmol/L (mg/dL) | 1.16 ± 0.190 (3.6 ± 0.6) |
| Magnesium,, mmol/L (mg/dL) | 1.1 ± 0.25 (2.2 ± 0.5) |
| 25(OH)D3, nmol/L (ng/mL) | 48.67 ± 24.96 (19.5 ± 10.0) |
| iPTH, ng/L (pg/mL) | 13.489 ± 8.78 (128.1 ± 83.4) |
| FGF-23, RU/mL | 137.2 ± 88.4 |
| Osteocalcin, nmol/L (µg/L) | 10.9 ± 8.5 (10.9 ± 8.5) |
| Malonaldehyde, µmol/L (nmol/mL) | 3.8 ± 1.2 (3.8 ± 1.2) |
| IL6, pg/mL | 6.2 ± 2.8 |
| HOMA-IR | 3.5 ± 2.5 |
| Characteristics . | Values . |
|---|---|
| Age (years) | 65.8 ± 9.2 |
| Gender (male/female) | 51/29 |
| Duration of disease (years) | 13.6 ± 4.9 |
| eGFR (mL/min/1.73 m2) | 49.8 ± 19.5 |
| SBP (mmHg) | 129.1 ± 12.1 |
| DBP (mmHg) | 78.8 ± 10.3 |
| Hg, g/L (g/dL) | 129 ± 15 (12.9 ± 1.5) |
| HgA1c, % | 7.1 ± 1.3 |
| Calcium, mmol/L (mg/dL) | 2.35 ± 0.175 (9.4 ± 0.7) |
| Phosphorus, mmol/L (mg/dL) | 1.16 ± 0.190 (3.6 ± 0.6) |
| Magnesium,, mmol/L (mg/dL) | 1.1 ± 0.25 (2.2 ± 0.5) |
| 25(OH)D3, nmol/L (ng/mL) | 48.67 ± 24.96 (19.5 ± 10.0) |
| iPTH, ng/L (pg/mL) | 13.489 ± 8.78 (128.1 ± 83.4) |
| FGF-23, RU/mL | 137.2 ± 88.4 |
| Osteocalcin, nmol/L (µg/L) | 10.9 ± 8.5 (10.9 ± 8.5) |
| Malonaldehyde, µmol/L (nmol/mL) | 3.8 ± 1.2 (3.8 ± 1.2) |
| IL6, pg/mL | 6.2 ± 2.8 |
| HOMA-IR | 3.5 ± 2.5 |
| Characteristics . | Values . |
|---|---|
| Age (years) | 65.8 ± 9.2 |
| Gender (male/female) | 51/29 |
| Duration of disease (years) | 13.6 ± 4.9 |
| eGFR (mL/min/1.73 m2) | 49.8 ± 19.5 |
| SBP (mmHg) | 129.1 ± 12.1 |
| DBP (mmHg) | 78.8 ± 10.3 |
| Hg, g/L (g/dL) | 129 ± 15 (12.9 ± 1.5) |
| HgA1c, % | 7.1 ± 1.3 |
| Calcium, mmol/L (mg/dL) | 2.35 ± 0.175 (9.4 ± 0.7) |
| Phosphorus, mmol/L (mg/dL) | 1.16 ± 0.190 (3.6 ± 0.6) |
| Magnesium,, mmol/L (mg/dL) | 1.1 ± 0.25 (2.2 ± 0.5) |
| 25(OH)D3, nmol/L (ng/mL) | 48.67 ± 24.96 (19.5 ± 10.0) |
| iPTH, ng/L (pg/mL) | 13.489 ± 8.78 (128.1 ± 83.4) |
| FGF-23, RU/mL | 137.2 ± 88.4 |
| Osteocalcin, nmol/L (µg/L) | 10.9 ± 8.5 (10.9 ± 8.5) |
| Malonaldehyde, µmol/L (nmol/mL) | 3.8 ± 1.2 (3.8 ± 1.2) |
| IL6, pg/mL | 6.2 ± 2.8 |
| HOMA-IR | 3.5 ± 2.5 |
| Characteristics . | Values . |
|---|---|
| Age (years) | 65.8 ± 9.2 |
| Gender (male/female) | 51/29 |
| Duration of disease (years) | 13.6 ± 4.9 |
| eGFR (mL/min/1.73 m2) | 49.8 ± 19.5 |
| SBP (mmHg) | 129.1 ± 12.1 |
| DBP (mmHg) | 78.8 ± 10.3 |
| Hg, g/L (g/dL) | 129 ± 15 (12.9 ± 1.5) |
| HgA1c, % | 7.1 ± 1.3 |
| Calcium, mmol/L (mg/dL) | 2.35 ± 0.175 (9.4 ± 0.7) |
| Phosphorus, mmol/L (mg/dL) | 1.16 ± 0.190 (3.6 ± 0.6) |
| Magnesium,, mmol/L (mg/dL) | 1.1 ± 0.25 (2.2 ± 0.5) |
| 25(OH)D3, nmol/L (ng/mL) | 48.67 ± 24.96 (19.5 ± 10.0) |
| iPTH, ng/L (pg/mL) | 13.489 ± 8.78 (128.1 ± 83.4) |
| FGF-23, RU/mL | 137.2 ± 88.4 |
| Osteocalcin, nmol/L (µg/L) | 10.9 ± 8.5 (10.9 ± 8.5) |
| Malonaldehyde, µmol/L (nmol/mL) | 3.8 ± 1.2 (3.8 ± 1.2) |
| IL6, pg/mL | 6.2 ± 2.8 |
| HOMA-IR | 3.5 ± 2.5 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
